Engineered Delivery Systems for Chinese Herbal Medicine in Peripheral Nerve Regeneration: Challenges, Advances, and Future Perspectives
Zhang R., Gu M., Ma R., Li R., Xu S., Xu Z.
Narrative Review on Chronic Inflammation, published in Drug Des Devel Ther (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Drug Des Devel Ther (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41281933
- PMCID
- PMC12640138
- DOI
- 10.2147/dddt.s563805
- Citations
- 1
Abstract (original English)
Peripheral neuropathy (PN), characterized by sensory, motor, and autonomic dysfunction, presents a significant therapeutic challenge owing to its diverse etiologies, dynamic spatiotemporal injury microenvironment, and impermeable blood-nerve barrier (BNB). The current treatment is mainly palliative and symptom-focused, and fails to solve the core pathological complexity, including the heterogeneity of nerve injury, the conflicting phases of inflammation, repair, and fibrosis, and the imbalance of the microenvironment in chronic conditions such as diabetes. Chinese herbal medicine (CHM) has multiple benefits including neuroprotective, anti-inflammatory, anti-oxidant, and microenvironmental regulation. However, its clinical translation is hindered by poor bioavailability, non-targeted biodistribution, BNB exclusion, and physicochemical mismatches in multicomponent formulations. Preclinical studies suggest that engineered delivery systems could emerge as a transformative solution to these limitations. Nanocarriers penetrate the BNB via diffusion or ligand-mediated targeting, offering spatiotemporal control through a stimulus-responsive design. Hydrogels align their degradation processes with nerve regeneration and correct the imbalanced microenvironments. Degradable membranes offer localized, sustained release, whereas functionalized nerve conduits address structural defects and i
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Comparing Regenerative Biologics and Standard Pharmacotherapy for Chronic Rotator Cuff Tendinopathy: A Study of PRP, Cell-Based, and Peptide Interventions
Systematic Review on Tendon Injury, Rotator Cuff, Shoulder Pain, Chronic Inflammation, published in J Orthop Sports Med (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Sports Med - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level ASystematic ReviewEurope PMC
Exosomes as Cellular Communicators and Therapeutic Agents in Orthopedic Diseases: From Mechanisms to Intervention
Systematic Review on Osteoarthritis, Chronic Inflammation, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.
- 2026
Int J Nanomedicine1 citations - Level ASystematic ReviewEurope PMC
Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review
Systematic Review on Chronic Inflammation, Immune Modulation, published in Front Oncol (2026) — summary generated from the PubMed abstract.
- 2026
Front Oncol - Level ASystematic ReviewEurope PMC
Trends in peripheral nerve injury research: a bibliometric analysis focused on molecular mechanisms
Systematic Review on Chronic Inflammation, published in Front Neurol (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurol